F.W.A. Verheugt

488 total citations
18 papers, 322 citations indexed

About

F.W.A. Verheugt is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, F.W.A. Verheugt has authored 18 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in F.W.A. Verheugt's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cardiac Imaging and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). F.W.A. Verheugt is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cardiac Imaging and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). F.W.A. Verheugt collaborates with scholars based in Netherlands, Germany and Poland. F.W.A. Verheugt's co-authors include Jurriën M. ten Berg, Christian M. Hackeng, Antonius A.C.M. Heestermans, Nicolas von Beckerath, Dirk Taubert, Machiel J. van Eenige, Jochem W. van Werkum, Edgar Schömig, C J Werter and Marc A. Brouwer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Heart.

In The Last Decade

F.W.A. Verheugt

16 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.W.A. Verheugt Netherlands 7 291 139 84 41 21 18 322
Cafer Zorkun Türkiye 11 312 1.1× 172 1.2× 157 1.9× 28 0.7× 22 1.0× 27 358
William G. O’Callaghan United States 11 442 1.5× 224 1.6× 123 1.5× 21 0.5× 28 1.3× 16 506
Teddy Weiss Israel 9 231 0.8× 118 0.8× 113 1.3× 24 0.6× 48 2.3× 16 316
Gotsman Ms Israel 10 246 0.8× 131 0.9× 63 0.8× 22 0.5× 48 2.3× 70 351
Alessandro Spirito United States 11 337 1.2× 164 1.2× 60 0.7× 36 0.9× 32 1.5× 48 416
Daniel Dulas United States 7 124 0.4× 112 0.8× 65 0.8× 18 0.4× 64 3.0× 11 225
Andrea Podczeck-Schweighofer Austria 10 255 0.9× 107 0.8× 31 0.4× 56 1.4× 8 0.4× 13 269
Kee‐Joon Choi South Korea 14 790 2.7× 56 0.4× 56 0.7× 25 0.6× 17 0.8× 64 835
T P Gavaghan Australia 9 432 1.5× 150 1.1× 64 0.8× 31 0.8× 98 4.7× 11 478
Avi Sabbag Israel 15 778 2.7× 221 1.6× 104 1.2× 26 0.6× 21 1.0× 72 820

Countries citing papers authored by F.W.A. Verheugt

Since Specialization
Citations

This map shows the geographic impact of F.W.A. Verheugt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.W.A. Verheugt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.W.A. Verheugt more than expected).

Fields of papers citing papers by F.W.A. Verheugt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.W.A. Verheugt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.W.A. Verheugt. The network helps show where F.W.A. Verheugt may publish in the future.

Co-authorship network of co-authors of F.W.A. Verheugt

This figure shows the co-authorship network connecting the top 25 collaborators of F.W.A. Verheugt. A scholar is included among the top collaborators of F.W.A. Verheugt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.W.A. Verheugt. F.W.A. Verheugt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Verheugt, F.W.A., et al.. (2009). Cardiac resynchronisation therapy: results from daily practice in Rijnstate Hospital, Arnhem. Netherlands Heart Journal. 17(1). 6–8. 4 indexed citations
2.
Heestermans, Antonius A.C.M., Jochem W. van Werkum, Dirk Taubert, et al.. (2008). Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction. Thrombosis Research. 122(6). 776–781. 135 indexed citations
3.
Wardeh, Alexander J., et al.. (2007). Percutaneous closure of an adult patent ductus arteriosus. Netherlands Heart Journal. 15(5). 196–197.
4.
Zegers, E. S., Helmut Gehlmann, & F.W.A. Verheugt. (2007). Acute myocardial infarction due to an acute type A aortic dissection involving the left main coronary artery. Netherlands Heart Journal. 15(8). 263–264. 15 indexed citations
5.
Verheugt, F.W.A., et al.. (2007). Posterior myocardial infarction: the dark side of the moon.. PubMed. 15(1). 16–21. 30 indexed citations
6.
Lamotte, Mark, et al.. (2006). Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation. International Journal of Clinical Practice. 60(9). 1129–1137. 7 indexed citations
7.
Brouwer, Marc A., et al.. (2005). Antiplatelet treatment for coronary heart disease. Heart. 93(2). 258–265. 38 indexed citations
8.
Brouwer, Marc A., et al.. (2004). Fibrinolysis and primary PCI for ST-elevation myocardial infarction: call for a more refined perspective.. PubMed. 12(7-8). 343–346. 1 indexed citations
9.
Swinkels, Ben M., et al.. (2003). Clinical significance of reverse redistribution on technetium-99m tetrofosmin single-photon emission computed tomography: an 18-month follow-up study.. PubMed. 11(3). 113–117. 1 indexed citations
10.
Bouwels, Leon, et al.. (2001). Factors influencing immediate and long-term outcome of electrical cardioversion of persistent atrial fibrillation and flutter.. PubMed Central. 9(1). 16–22. 5 indexed citations
11.
Verheugt, F.W.A.. (1998). Differential Dose Effect of Aspirin in the Primary Prevention of Myocardial Infarction. Journal of the American College of Cardiology. 31(2). 352A–352A. 2 indexed citations
12.
Verheugt, F.W.A.. (1998). The Early Risk of Thrombolytic Therapy for Acute Myocardial Infarction: Incidence, Mechanisms and Possible Prevention. European Journal of Cardiovascular Prevention & Rehabilitation. 5(2). 103–108. 2 indexed citations
13.
Heerschap, Arend, et al.. (1997). ATP Content Measured by31P NMR Correlates with Post-ischaemic Recovery of External Work Output in an Isolated Rat Heart Perfused with Erythrocyte Suspension. Journal of Molecular and Cellular Cardiology. 29(6). 1763–1766. 4 indexed citations
14.
Verheugt, F.W.A.. (1996). [Is heart transplantation in The Netherlands only for the lucky few?].. PubMed. 140(47). 2321–2.
15.
Meijer, Albert, F.W.A. Verheugt, Machiel J. van Eenige, & C J Werter. (1994). Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.. Circulation. 90(4). 1706–1714. 50 indexed citations
16.
Galema, Tjebbe W. & F.W.A. Verheugt. (1990). [Antithrombotic agents in coronary bypass surgery in The Netherlands].. PubMed. 134(34). 1632–6. 1 indexed citations
17.
Küpper, Albert J. Funke, et al.. (1989). Comparison of Two Latex Agglutination Test Kits for Serum Myoglobin in the Exclusion of Acute Myocardial Infarction. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 26(3). 254–258. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026